Hossein Tabriziani MD FACP , FASN
Kidney & Pancreas Transplantation
Transplant Nephrologist
Join to View Full Profile
HossMed, IncSan Diego, CA 92101
Dr. Tabriziani is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of California (San Francisco) School of MedicineFellowship, Transplsnt, 2012 - 2013
MedStar Health Georgetown UniversityFellowship, Nephrology, 2010 - 2012
St Barnabas HospitalResidency, Internal Medicine, 1999 - 2002
Iran University of Medical SciencesClass of 1995
Certifications & Licensure
CA State Medical License 2002 - 2025
IL State Medical License 2020 - 2023
DC State Medical License 2010 - 2018
NY State Medical License 2009 - 2015
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Nephrology
Awards, Honors, & Recognition
- FASN ASN , American Society of Nephrology, 2015
- FACP ACP , American College of Physician, 2008
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012
Publications & Presentations
PubMed
- 2 citationsDeveloping Therapies for C3 Glomerulopathy: Report of the Kidney Health Initiative C3 Glomerulopathy Trial Endpoints Work Group.Carla Nester, Dima A Decker, Matthias Meier, Shakil Aslam, Andrew S Bomback
Clinical Journal of the American Society of Nephrology. 2024-09-01 - 9 citationsElevation of Donor-derived Cell-free DNA Before Biopsy-proven Rejection in Kidney Transplant.Jonathan S Bromberg, Suphamai Bunnapradist, Milagros Samaniego-Picota, Sanjiv Anand, Erik Stites
Transplantation. 2024-09-01 - Townes-Brocks Syndrome Revealed by Kidney Gene Panel Testing.Quinn Stein, Anna Vostrizansky, Yelena Magay, Sara Jandeska, Maggie Westemeyer
Kidney International Reports. 2024-06-01
Press Mentions
Natera Announces Definitive Study to Evaluate the Clinical Utility of Renasight in the Diagnosis and Management of Chronic Kidney Disease (CKD)April 28th, 2022- Natera Announces New Prospera™ Data at the ATC 2021 Virtual Connect ConferenceJune 4th, 2021
- Natera Announces New Prospera™ Data at the ATC 2021 Virtual Connect ConferenceJune 4th, 2021
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
